Humana Inc. (HUM) concluded trading on Thursday at a closing price of $251.44, with 2.44 million shares of worth about $613.1 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.50% during that period and on October 10, 2024 the price saw a gain of about 2.44%. Currently the company’s common shares owned by public are about 122.22M shares, out of which, 120.10M shares are available for trading.
Stock saw a price change of 4.00% in past 5 days and over the past one month there was a price change of -23.39%. Year-to-date (YTD), HUM shares are showing a performance of -45.08% which decreased to -49.75% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $213.31 but also hit the highest price of $530.54 during that period. The average intraday trading volume for Humana Inc. shares is 1.81 million. The stock is currently trading -12.64% below its 20-day simple moving average (SMA20), while that difference is down -23.10% for SMA50 and it goes to -29.15% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Humana Inc. (NYSE: HUM) currently have 122.22M outstanding shares and institutions hold larger chunk of about 95.55% of that.
The stock has a current market capitalization of $30.27B and its 3Y-monthly beta is at 0.51. PE ratio of stock for trailing 12 months is 17.92, while it has posted earnings per share of $14.03 in the same period. Its PEG reads 3.58 while making debt-to-equity ratio of 0.77. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HUM, volatility over the week remained 2.69% while standing at 3.62% over the month.
Stock’s fiscal year EPS is expected to drop by -38.06% while it is estimated to increase by 22.41% in next year. EPS is likely to shrink at an annualized rate of 5.00% for next 5-years, compared to annual growth of 10.46% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Bernstein on October 08, 2024 offering an Outperform rating for the stock and assigned a target price of $308 to it. Coverage by TD Cowen stated Humana Inc. (HUM) stock as a Hold in their note to investors on October 07, 2024, suggesting a price target of $261 for the stock. On October 07, 2024, Jefferies Downgrade their recommendations, while on October 03, 2024, Piper Sandler Downgrade their ratings for the stock with a price target of $274. Stock get an Equal-weight rating from Stephens on October 02, 2024.
